CONMED CORPORATION (NASDAQ:CNMD) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders.
The annual meeting of shareholders of CONMED Corporation was held
on May 24, 2017 (the Annual Meeting). Holders of Common Stock
were entitled to elect ten directors. On all matters which came
before the Annual Meeting, holders of Common Stock were entitled
to one vote for each share held. Proxies for 26,626,550 of the
27,871,672 shares of Common Stock entitled to vote were received
in connection with the Annual Meeting.
The following table sets forth the names of the ten persons
elected at the Annual Meeting to serve as directors until the
first annual meeting of shareholders following the end of the
Companys fiscal year ending December 31, 2017 and the number of
votes cast for, against or withheld with respect to each person.
Election of Directors
| Director | Votes Received | Votes Withheld | Broker Non-Votes |
| David Bronson | 25,336,383 | 253,377 | 1,036,790 |
| Brian P. Concannon | 25,320,090 | 269,670 | 1,036,790 |
| Charles M. Farkas | 25,297,823 | 291,937 | 1,036,790 |
| Martha Goldberg Aronson | 25,283,154 | 306,606 | 1,036,790 |
| Jo Ann Golden | 25,269,494 | 320,266 | 1,036,790 |
| Curt R. Hartman | 25,347,054 | 242,706 | 1,036,790 |
| Dirk M. Kuyper | 25,253,975 | 335,785 | 1,036,790 |
| Jerome J. Lande | 25,282,303 | 307,457 | 1,036,790 |
| Mark E. Tryniski | 25,319,847 | 269,913 | 1,036,790 |
| John L. Workman | 25,347,109 | 242,651 | 1,036,790 |
Management Proposals
|
For |
Against |
Abstain |
Broker Non-Votes | ||
|
Ratification of the appointment of PricewaterhouseCoopers
LLP as independent registered public accounting firm for |
26,313,701 | 298,427 | 14,422 | ||
| Approve advisory vote on Named Executive Officer compensation | 25,169,847 | 395,495 | 24,418 | 1,036,790 | |
| Approve the Executive Bonus Plan | 25,164,627 | 361,365 | 63,768 | 1,036,790 | |
|
One Year |
Two Years |
Three Years | Abstain |
Broker Non-Votes |
|
|
Approval of advisory vote on the frequency of future advisory votes on executive compensation |
20,775,987 |
31,804 |
4,751,990 |
29,979 |
1,036,790 |
Item 8.01 Other Events
On May 24, 2017, CONMED Corporation announced it will be paying a
quarterly cash dividend of $0.20 per share on July 5, 2017 to all
shareholders of record as of June 15, 2017.
About CONMED CORPORATION (NASDAQ:CNMD)
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. Its products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. Its product lines consist of orthopedic surgery, general surgery and surgical visualization. Its orthopedic surgery product lines include sports medicine, powered surgical instruments, and sports biologics and tissue. Its general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies and critical care. Its surgical visualization product line offers imaging systems for use in minimally invasive orthopedic and general surgery procedures. Its products are distributed domestically directly to over 6,000 hospitals and other healthcare institutions, as well as through medical specialty distributors. CONMED CORPORATION (NASDAQ:CNMD) Recent Trading Information
CONMED CORPORATION (NASDAQ:CNMD) closed its last trading session up +0.51 at 50.47 with 110,372 shares trading hands.
